|
Welcome,
Guest
|
Profile for Brodalumab for the treatment moderate-to-severe plaque-type epidermis: any real-life, retrospective 24-week expertise. (spacebranch27)
|
Signature
|
|
Welcome,
Guest
|
|
Signature
|